Search clinical trials for: Isatuximab
Total 146 results
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Cryoglobulinemic Vasculitis
-
Massachusetts General HospitalSanofi; PfizerNot yet recruitingRelapsed Refractory Multiple Myeloma | Relapsed Refractory Multiple Myeloma (RRMM)United States
-
Thomas Martin, MDWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Firas El Chaer, MDTerminatedHematologic Malignancy | Platelet RefractorinessUnited States
-
Memorial Sloan Kettering Cancer CenterSanofiRecruitingBlood Cancer | Refractory Immune CytopeniasUnited States
-
Columbia UniversityGenzyme, a Sanofi CompanyRecruitingMonoclonal GammopathyUnited States
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)Netherlands, Germany, Italy, United Kingdom, United States, France
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Karolinska InstitutetSanofi; XNK Therapeutics AB, SwedenRecruiting
-
SanofiCompleted
-
SanofiCompletedPlasma Cell MyelomaUnited States, Czechia, France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingSmoldering Plasma Cell MyelomaUnited States
-
SanofiCompleted
-
Won Seog KimSanofiRecruitingNatural Killer/T-cell Lymphoma | Relapsed Natural Killer/T-cell Lymphoma | Refractory Natural Killer/T-cell LymphomaKorea, Republic of
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingNausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary AmyloidosisUnited States
-
Canadian Myeloma Research GroupActive, not recruiting
-
National Cancer Institute (NCI)TerminatedCarcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Mesothelioma | Carcinoma, Pancreatic DuctalUnited States
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Taylor BrooksAbbVie; Genmab; Recordati Rare DiseasesRecruitingNon-Hodgkin Lymphoma | Cytokine Release SyndromeUnited States
-
University of Alabama at BirminghamRecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Acute Lymphoblastic Leukemia | Cytokine Release Syndrome | ICANSUnited States
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Janssen Research & Development, LLCCompletedMultiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Plasma Cell NeoplasmUnited States, Belgium, Russian Federation
-
Daiichi SankyoAstraZenecaRecruitingMetastatic Cancer | Advanced CancerSpain, Italy, United States, Korea, Republic of, Belgium, France, Israel, Australia, Japan, Taiwan, United Kingdom, Brazil
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteEUSA Pharma, Inc.Active, not recruitingLarge Granular Lymphocyte LeukemiaUnited States
-
Centocor, Inc.CompletedCarcinoma, Renal CellFrance, United Kingdom, Netherlands, Czech Republic
-
EusaPharma (UK) LimitedTerminatedIdiopathic Multicentric Castleman's DiseaseUnited States
-
NYU Langone HealthWithdrawnAntibody-mediated Rejection | AllosensitizationUnited States
-
Tufts Medical CenterSanofiWithdrawnAmyloidosis | Light Chain (AL) Amyloidosis
-
SanofiTerminatedLymphomaKorea, Republic of, Portugal, France, Taiwan, Italy, Netherlands, Spain
-
Deborah Yurgelun-ToddCompletedNeurocognitive ImprovementUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
Jack Khouri, MDWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Cytokine Release Syndrome | Immune Effector Cell Associated Neurotoxicity SyndromeUnited States
-
OHSU Knight Cancer InstituteSanofi; Oregon Health and Science UniversityActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Carla Greenbaum, MDJanssen Research & Development, LLCCompleted
-
Centocor, Inc.CompletedLymphoma, Non-Hodgkin | Multiple Myeloma | Giant Lymph Node HyperplasiaUnited States
-
Nantes University HospitalRecruiting
-
EusaPharma (UK) LimitedSyneos HealthTerminatedRespiratory Tract Infections | Pneumonia | Lung Diseases | Acute Respiratory Distress Syndrome | Respiratory Tract DiseaseUnited States
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMulticentric Castleman's DiseaseUnited States, Canada, France, United Kingdom, China, Germany, Taiwan, Spain, Israel, Korea, Republic of, Singapore, Brazil, Belgium, New Zealand, Norway, Egypt, Hong Kong
-
Goethe UniversitySanofiRecruiting
-
Centocor, Inc.Completed
-
Brian MillerStanley Medical Research InstituteRecruiting
-
University of Texas Southwestern Medical CenterStanley Medical Research InstituteCompletedBipolar Disorder | Major Depressive Disorder | Amphetamine Dependence | Amphetamine AbuseUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMultiple Myeloma | AL AmyloidosisUnited States
-
Janssen Research & Development, LLCTerminatedMyelodysplastic SyndromeUnited States, Belgium, Spain, Australia, Sweden, Netherlands, Russian Federation
-
University of Illinois at ChicagoHuntsman Cancer InstituteRecruiting
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
SanofiTerminatedNeoplasmSpain, Taiwan, Italy, Czechia, United States, Belgium, Canada, Netherlands